Emcure Pharmaceuticals Limited (BOM:544210)

Allakos Revenue

Emcure Pharmaceuticals had revenue of 21.01B INR in the quarter ending June 30, 2025, with 15.72% growth. This brings the company's revenue in the last twelve months to 81.81B, up 18.28% year-over-year. In the fiscal year ending March 31, 2025, Emcure Pharmaceuticals had annual revenue of 78.96B with 18.59% growth.

• Revenue (ttm): 81.81B
• Revenue Growth: +18.28%
• P/S Ratio: 3.21
• Revenue / Employee: 12.15M
• Employees: 6,731
• Market Cap: 262.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	78.96B	12.38B	18.59%
Mar 31, 2024	66.58B	6.72B	11.23%
Mar 31, 2023	59.86B	1.30B	2.23%
Mar 31, 2022	58.55B	8.22B	16.33%
Mar 31, 2021	50.33B	-150.80M	-0.30%